SCHEMBL10067973

SCHEMBL10067973

O=C(NCC1CCCO1)c1nc(-n2nnnc2-c2ccccc2F)c[nH]1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.51
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 5/20 0.45
HPGD P15428 5/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GSK3B P49841 1/20 0.43
KCNH2 Q12809 1/20 0.43
HTT P42858 2/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14286155 0.83 NPC1 (0.53) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL10067975 0.80 ALDH1A1 (0.46) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL10067395 0.75 GSK3B (0.49) RAB9ANPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL10067970 0.74 PTGES (0.39) RAB9ANPC1ALDH1A1LMNAPOLB
SCHEMBL14278771 0.72 MAPK1 (0.49) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL14600777 0.72 GSK3B (0.53) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL14600753 0.71 GSK3B (0.53) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL10067976 0.70 GSK3B (0.44) RAB9ANPC1ALDH1A1HPGDMEN1
SCHEMBL14600774 0.70 GSK3B (0.45) RAB9ANPC1ALDH1A1HPGDKDM4E
SCHEMBL14600779 0.69 MEN1 (0.46) RAB9ANPC1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697352-B1 4-AZOLE SUBSTITUTED IMIDAZOLE COMPOSITIONS USEFUL AS INHIBITORS OR C-MET RECEPTOR TYROSINE KINASE VERTEX PHARMA (US) 2012-06-27 EP disclosed
US-7169800-B2 Imidazole compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-01-30 US disclosed